FONDAPARINUX 2.5 MG/0.5 ML SYR
Fondaparinux 2.5 mg/0.5 ml syringes have a Medicare acquisition cost of $28.11, though hospitals typically charge 8-15 times this amount for the same anticoagulant medication.
About the analyst
Michael Glenn reviews CMS datasets and drug pricing at BillRazor Research. He focuses on NADAC acquisition costs and procedure coding accuracy. Expertise: drug pricing, NADAC data, CPT coding.
Fondaparinux is an anticoagulant injection used to prevent blood clots, typically administered in hospital or outpatient settings following surgery or for certain medical conditions. This medication often requires prior authorization from insurers and may have significant cost variations between different healthcare facilities.
No credit card required. Results in 60 seconds.
Common billing errors — Anticoagulants charges
Anticoagulant billing presents several recurring issues for hospital patients. Generic substitution errors frequently occur when hospitals bill for brand-name warfarin or enoxaparin while dispensing generic equivalents, creating potential differences of 200-400% above acquisition costs. Duplicate billing commonly appears when patients receive both oral and injectable anticoagulants during transitions, with charges for overlapping days appearing on the same statement. Hospital markups on this drug class typically range from 300-800% above the average NADAC benchmark of $18.84, with some institutions charging $150-200 for medications with acquisition costs under $25. Dosing consolidation errors also create billing discrepancies when multiple small-dose administrations are billed separately instead of as combined therapeutic doses, particularly with heparin protocols. Patients should verify that billed quantities match actual administration records and confirm whether generic or brand medications were dispensed, as charges above benchmark pricing are most pronounced in this therapeutic category due to frequent hospital inventory practices.
What to check on your bill
When reviewing anticoagulant charges on your hospital bill, examine the pharmacy section for specific drug names like warfarin, heparin, enoxaparin (Lovenox), or rivaroxaban (Xarelto). Check for duplicate entries across different billing days, as anticoagulants are often administered multiple times daily. Look for charges listed under both "pharmacy" and "medical supplies" sections, which may indicate double billing for the same medication. Verify dosage amounts match your medical records, as anticoagulant doses vary significantly by patient weight and condition. Review any charges above the benchmark for brand-name anticoagulants when generic equivalents were administered. Pay attention to administration fees listed separately from the drug cost itself, particularly for injectable anticoagulants like heparin. Compare daily anticoagulant charges for consistency, as unexplained variations may indicate billing errors. Check if charges for monitoring tests like PT/INR or anti-Xa levels appear under laboratory services, as these are separate from the medication costs and should not be bundled with drug charges.
FAQ — Anticoagulants billing
What is the average acquisition cost for anticoagulant drugs?
How many drugs are included in the anticoagulant class for billing analysis?
How can I identify charges above the benchmark for anticoagulant medications?
What should I consider when reviewing anticoagulant drug billing?
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.